Skip to main content
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.390
-0.050 (-1.15%)
Feb 11, 2025, 2:05 PM EST - Market open

ZYBT Revenue

Zhengye Biotechnology Holding had revenue of 94.95M CNY in the half year ending June 30, 2024, a decrease of -23.03%. This brings the company's revenue in the last twelve months to 189.75M, down -25.23% year-over-year. In the year 2023, Zhengye Biotechnology Holding had annual revenue of 211.65M, down -18.68%.

Revenue (ttm)
189.75M CNY
Revenue Growth
-25.23%
P/S Ratio
7.61
Revenue / Employee
663,455 CNY
Employees
286
Market Cap
207.06M USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ZYBT News

More News